John Gaspar, PhD

Merck and Co.

Disclosure(s): No financial relationships to disclose

Poster(s):

• 153 - Molnupiravir Exhibits a High Barrier to the Development of SARS-CoV-2 Resistance in vitro
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET